Sequence complementarity between human noncoding RNAs and SARS-CoV-2 genes: What are the implications for human health?


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 02 2022
Historique:
received: 24 05 2021
revised: 17 09 2021
accepted: 09 10 2021
pubmed: 19 10 2021
medline: 11 1 2022
entrez: 18 10 2021
Statut: ppublish

Résumé

To investigate in silico the presence of nucleotide sequence complementarity between the RNA genome of Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) and human non-coding (nc)RNA genes. The FASTA sequence (NC_045512.2) of each of the 11 SARS-CoV-2 isolate Wuhan-Hu-1 genes was retrieved from NCBI.nlm.nih.gov/gene and the Ensembl.org library interrogated for any base-pair match with human ncRNA genes. SARS-CoV-2 gene-matched human ncRNAs were screened for functional activity using bioinformatic analysis. Finally, associations between identified ncRNAs and human diseases were searched in GWAS databases. A total of 252 matches were found between the nucleotide sequence of SARS-CoV-2 genes and human ncRNAs. With the exception of two small nuclear RNAs, all of them were long non-coding (lnc)RNAs expressed mainly in testis and central nervous system under physiological conditions. The percentage of alignment ranged from 91.30% to 100% with a mean nucleotide alignment length of 17.5 ± 2.4. Thirty-three (13.09%) of them contained predicted R-loop forming sequences, but none of these intersected the complementary sequences of SARS-CoV-2. However, in 31 cases matches fell on ncRNA regulatory sites, whose adjacent coding genes are mostly involved in cancer, immunological and neurological pathways. Similarly, several polymorphic variants of detected non-coding genes have been associated with neuropsychiatric and proliferative disorders. This pivotal in silico study shows that SARS-CoV-2 genes have Watson-Crick nucleotide complementarity to human ncRNA sequences, potentially disrupting ncRNA epigenetic control of target genes. It remains to be elucidated whether this could result in the development of human disease in the long term.

Identifiants

pubmed: 34662705
pii: S0925-4439(21)00224-6
doi: 10.1016/j.bbadis.2021.166291
pmc: PMC8518135
pii:
doi:

Substances chimiques

RNA, Long Noncoding 0
RNA, Untranslated 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166291

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Références

Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Front Biosci (Schol Ed). 2009 Jun 01;1(1):226-35
pubmed: 19482698
Rheumatology (Oxford). 2019 Feb 1;58(2):289-298
pubmed: 30247649
Methods Mol Biol. 2014;1165:115-43
pubmed: 24839023
Diagnostics (Basel). 2020 Sep 28;10(10):
pubmed: 32998396
Nucleic Acids Res. 2015 Jul 1;43(W1):W527-34
pubmed: 25883153
Clin Chim Acta. 2011 Jul 15;412(15-16):1457-61
pubmed: 21496453
PLoS Genet. 2012 Jan;8(1):e1002455
pubmed: 22291604
Geriatrics (Basel). 2021 Jan 26;6(1):
pubmed: 33530357
Nat Med. 2017 Nov;23(11):1331-1341
pubmed: 29035371
Oncotarget. 2015 Oct 20;6(32):32841-55
pubmed: 26418880
Biochem Biophys Res Commun. 2020 Jun 4;526(3):670-677
pubmed: 32248969
Front Immunol. 2019 Jan 25;9:3138
pubmed: 30740112
Autoimmun Rev. 2020 Jul;19(7):102575
pubmed: 32376395
Mayo Clin Proc. 2020 Jul;95(7):1445-1453
pubmed: 32622449
Gene. 2016 Jul 1;585(1):128-134
pubmed: 26997260
Lancet Respir Med. 2021 Mar;9(3):251-259
pubmed: 33341155
QJM. 2019 Oct 1;112(10):749-755
pubmed: 30605546
PLoS One. 2018 Jun 18;13(6):e0198945
pubmed: 29912916
Int J Biochem Cell Biol. 2018 Oct;103:125-134
pubmed: 30142387
CJC Open. 2019 Jul 02;1(5):245-255
pubmed: 32159116
Basic Clin Neurosci. 2020 Mar-Apr;11(2):217-224
pubmed: 32855781
Cell. 2014 Sep 25;159(1):188-199
pubmed: 25259926
Cell Syst. 2020 Jul 22;11(1):102-108.e3
pubmed: 32673562
Nat Genet. 2012 Sep;44(9):981-90
pubmed: 22885922
mBio. 2010 Oct 26;1(5):
pubmed: 20978541
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Am J Physiol Lung Cell Mol Physiol. 2021 Jun 1;320(6):L1147-L1157
pubmed: 33851876
Oral Dis. 2019 Mar;25(2):372-384
pubmed: 29316023
Cancer Treat Res Commun. 2021;26:100285
pubmed: 33360669
Noncoding RNA. 2019 Jan 14;5(1):
pubmed: 30646609
Nat Rev Nephrol. 2016 Jun;12(6):325-38
pubmed: 27108839
Annu Rev Immunol. 2017 Apr 26;35:177-198
pubmed: 28125358
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):17121-17126
pubmed: 31399544
Transl Res. 2018 Jan;191:29-44
pubmed: 29154757
Int J Mol Med. 2018 Aug;42(2):713-725
pubmed: 29786110
Nat Genet. 2013 Nov;45(11):1353-60
pubmed: 24076602
Front Immunol. 2020 Oct 09;11:590870
pubmed: 33163005
Mol Cancer. 2020 Mar 24;19(1):64
pubmed: 32209098
J Cell Mol Med. 2021 May;25(10):4753-4764
pubmed: 33759345
PLoS One. 2013;8(3):e58352
pubmed: 23472185
Trends Neurosci. 2020 Jun;43(6):355-357
pubmed: 32359765
RNA. 2015 Dec;21(12):2007-22
pubmed: 26574518
J Invest Dermatol. 2019 Jun;139(6):1373-1384
pubmed: 30594489
J Cell Biochem. 2020 Oct;121(10):4085-4093
pubmed: 31916281
Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12):
pubmed: 28246180
J Alzheimers Dis. 2015;48(2):319-53
pubmed: 26401998
BMJ. 2020 Mar 26;368:m1198
pubmed: 32217618
World J Clin Cases. 2020 Sep 6;8(17):3621-3644
pubmed: 32953841
Front Immunol. 2019 Mar 19;10:502
pubmed: 30941136
Int J Rheum Dis. 2015 Mar;18(3):294-303
pubmed: 25884792
Hum Mol Genet. 2016 Jan 1;25(1):180-90
pubmed: 26546613
Curr Opin Immunol. 2014 Feb;26:140-6
pubmed: 24556411
Ann Transl Med. 2020 Nov;8(22):1508
pubmed: 33313253
Genome Res. 2012 Sep;22(9):1775-89
pubmed: 22955988
J Clin Invest. 2017 Mar 1;127(3):761-771
pubmed: 28248199
Nature. 2014 Feb 20;506(7488):376-81
pubmed: 24390342
Int Immunopharmacol. 2017 Jun;47:141-149
pubmed: 28395256
Nat Genet. 2013 Jul;45(7):730-8
pubmed: 23749187
Bone Marrow Transplant. 2017 Jan;52(1):95-100
pubmed: 27595289
Nat Commun. 2020 Nov 27;11(1):6059
pubmed: 33247099
Science. 2017 Nov 24;358(6366):1051-1055
pubmed: 29074580
Front Bioeng Biotechnol. 2021 Jan 15;8:582953
pubmed: 33520952
Nat Commun. 2019 Nov 25;10(1):5334
pubmed: 31767869
Sci Rep. 2016 Dec 23;6:39831
pubmed: 28008999
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
N Engl J Med. 2020 Aug 20;383(8):789-790
pubmed: 32530585
Ann Rheum Dis. 2017 Jan;76(1):286-294
pubmed: 27193031
Nucleic Acids Res. 2017 Jul 3;45(W1):W435-W439
pubmed: 28472523
Am J Hum Genet. 2015 Jan 8;96(1):104-20
pubmed: 25574825
Obesity (Silver Spring). 2020 Nov;28(11):2049-2055
pubmed: 32735706
Life Sci. 2020 Sep 15;257:118114
pubmed: 32693241
Exp Ther Med. 2019 Nov;18(5):3579-3587
pubmed: 31608128
Hum Mol Genet. 2013 Oct 1;22(19):4021-9
pubmed: 23740937
PLoS One. 2018 Oct 31;13(10):e0206511
pubmed: 30379917
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Nat Rev Rheumatol. 2010 May;6(5):280-9
pubmed: 20431553
Front Cell Infect Microbiol. 2017 May 26;7:205
pubmed: 28603696
Future Virol. 2020 Sep;15(9):577-593
pubmed: 33224264
Cell. 2011 Aug 5;146(3):353-8
pubmed: 21802130
Essays Biochem. 2013;54:79-90
pubmed: 23829528
Nat Rev Cancer. 2010 Dec;10(12):878-89
pubmed: 21102637
Signal Transduct Target Ther. 2020 Dec 24;5(1):294
pubmed: 33361761
Nucleic Acids Res. 2019 Jan 8;47(D1):D601-D606
pubmed: 30445601
Cancer Cell Int. 2020 Jun 05;20:215
pubmed: 32518524
Reumatologia. 2015;53(2):94-100
pubmed: 27407234
Respir Res. 2020 Jul 14;21(1):182
pubmed: 32664949
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Biotechniques. 2000 Jun;28(6):1102, 1104
pubmed: 10868275
Hum Mol Genet. 2019 Dec 1;28(23):4022-4041
pubmed: 31361310
Genes (Basel). 2020 Jul 07;11(7):
pubmed: 32646047
Genomics. 2015 Feb;105(2):108-15
pubmed: 25451679
Cancer Lett. 2018 Nov 28;437:56-66
pubmed: 30165194
Nat Genet. 2008 Sep;40(9):1059-61
pubmed: 19165918
Rheumatol Int. 2008 Apr;28(6):579-83
pubmed: 17938929
Hum Mol Genet. 2019 Mar 1;28(5):858-874
pubmed: 30423114
Oncotarget. 2017 Oct 24;8(61):104113-104122
pubmed: 29262625
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118
pubmed: 33353982
Eur Rev Med Pharmacol Sci. 2020 Nov;24(21):11395-11401
pubmed: 33215461
Noncoding RNA. 2021 Feb 18;7(1):
pubmed: 33670580
Sci Rep. 2021 Apr 12;11(1):7991
pubmed: 33846375
Nat Genet. 2016 May;48(5):510-8
pubmed: 26974007
Autoimmunity. 2005 Feb;38(1):47-54
pubmed: 15804705
Adv Ther. 2020 Jul;37(7):3033-3039
pubmed: 32504450
Nucleic Acids Res. 2020 Jan 8;48(D1):D189-D197
pubmed: 31906603
Int Immunopharmacol. 2021 Jul;96:107497
pubmed: 33831808
Nat Genet. 2017 Feb;49(2):262-268
pubmed: 28067912
Nat Genet. 2016 Nov;48(11):1425-1429
pubmed: 27723758

Auteurs

Rossella Talotta (R)

Department of Clinical and Experimental Medicine, Rheumatology Unit, AOU "Gaetano Martino", University of Messina, Messina, Italy. Electronic address: rtalotta@unime.it.

Shervin Bahrami (S)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.

Magdalena Janina Laska (MJ)

Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark. Electronic address: laska@mbg.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH